Cresset Asset Management’s CareDx CDNA Stock Holding History

Cresset Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,200	Closed	-$202K	–	1107
2021 Q2	$202K	Buy	+2,200	New	+$175K	﹤0.01%	948
2019 Q2	–	Sell	-1,579	Closed	-$50K	–	672
2019 Q1	$50K	Hold	1,579	–	–	﹤0.01%	775
2018 Q4	$40K	Buy	+1,579	New	+$40.6K	﹤0.01%	546

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Cresset Asset Management's CDNA Position: Q3 2021 in Review

Cresset Asset Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 2,200 shares — an estimated $202K sold.

Cresset Asset Management first reported a position in CDNA in Q4 2018 and held it in 3 quarters. The position peaked at $202K in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

Cresset Asset Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
Cresset Asset Management sold 2,200 CareDx shares in Q3 2021, an estimated $202K.
Cresset Asset Management first reported a position in CareDx in Q4 2018 and held it in 3 quarters.
Cresset Asset Management's CareDx position peaked at $202K in Q2 2021.
260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.